CNO Financial Group, Inc. (CNO) · Oct 29, 2026 · Earnings

CNO earnings beat, guidance raised as actuarial gains flatter print

Beat — Operating EPS $1.90 vs ~$1.10 consensus; $1.42 excluding significant items

CNO earnings beat Q3 expectations and raised full-year operating EPS guidance, with underlying insurance profits improving despite a large actuarial tailwind.

CNO is a middle-income-focused insurer selling life, health and annuity products through Consumer and Worksite distribution, currently trying to convert several quarters of sales momentum into more durable profitability. Its prior-quarter update highlighted 16 consecutive quarters of insurance-sales growth and had already lifted 2026 operating EPS guidance, so the setup was constructive rather than distressed.

The quarter beat the published bar by a wide margin. Net operating EPS was $1.90 versus roughly $1.10 consensus, while total revenue was $1.086 billion versus roughly $1.01 billion expected. That is a clear earnings beat, although revenue still fell 8.6% year over year because investment losses and lower fee income offset higher insurance policy income. The filing states: “Net income was $161 million, or $1.71 per diluted share, and net operating income(1) was $179 million, or $1.90 per diluted share.”

3Q263Q25Consensus
Total revenues (Income Statement)$1,086.0M (-8.6%)$1,188.7M~$1,010M
Net income per diluted share (Income Statement)$1.71 (+612.5%)$0.24~$1.10
Net operating income per diluted share (Financial Highlights)$1.90 (+47.3%)$1.29—
Net operating income per diluted share, excluding significant items (Significant Items)$1.42 (+47.9%)$0.96—
Operating ROE, excluding significant items (Ratios)14.1%11.2%—

The beat was not only an actuarial artifact, but the headline overstates the underlying acceleration. CNO received a $44.9 million, or $0.48 per share, favorable impact from its annual actuarial review; stripping that out still leaves $1.42 of operating EPS, comfortably above the published expectation. Insurance product income rose 15% to $172.0 million, with annuity and life margins improving, while health margin declined from the year-ago quarter. The filing says: “Significant items related to the comprehensive annual actuarial review had a $44.9 million net favorable impact on both net income and net operating income.”

Management raised the full-year operating EPS outlook again, reinforcing the profitability story. The filing gives no revised numerical range in the provided text, so the size of the increase cannot be assessed precisely; qualitatively, this is more than a routine reaffirmation and follows the guidance increase disclosed after the second quarter. The company states: “Based on these results, we are raising our full-year operating earnings per share guidance.” 〔0〕

Capital deployment and reinsurance remain supportive, but secondary to the earnings signal. CNO repurchased $60.0 million of stock during the quarter and, on October 1, completed a third Bermuda-affiliate reinsurance transaction covering approximately $270 million of Colonial Penn graded-benefit life reserves. Those actions fit the company’s effort to optimize capital and improve returns, but they do not change the central Q3 read: underlying operating performance cleared expectations even after removing the actuarial benefit.

Bottom line: This was a genuine earnings beat with another guidance increase, not merely a favorable accounting swing. The actuarial gain amplified the headline, but the underlying $1.42 operating EPS still points to better business performance than the market had expected.

What to watch next

Q3 earnings call, October 30, 2026

Original filing on SEC EDGAR

More CNO Financial Group, Inc. news

CNO earnings beat, guidance raised as actuarial gains flatter print | CNO Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.